Call us
+44 1204 543 529
Company Report

F. Hoffmann-La Roche Ltd. - Product Pipeline Review - Q4 2010

Published: Nov-2010
  • Adobe PDF
  • Global Market Direct’s pharmaceuticals report, “F. Hoffmann-La Roche Ltd. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

    This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.


    F. Hoffmann-La Roche Ltd. Brief company overview including business description, key information and facts, and its locations and subsidiaries.

    Review of current pipeline of F. Hoffmann-La Roche Ltd. human therapeutic division.

    Overview of pipeline therapeutics across various therapy areas.

    Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

    Product profiles for late stage and clinical stage products of F. Hoffmann-La Roche Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.

    Recent updates of the F. Hoffmann-La Roche Ltd.’s pipeline in the last quarter.

    Key discontinued and dormant projects.

    Latest news and deals relating to the products.

    Reasons To Buy

    • Evaluate F. Hoffmann-La Roche Ltd.’s strategic position with total access to detailed information on its product pipeline.
    • Assess the growth potential of F. Hoffmann-La Roche Ltd. in its therapy areas of focus.
    • Identify new drug targets and therapeutic classes in the F. Hoffmann-La Roche Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
    • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
    • Exploit collaboration and partnership opportunities with F. Hoffmann-La Roche Ltd..
    • Avoid Intellectual Property Rights related issues.
    • Explore the dormant and discontinued projects of F. Hoffmann-La Roche Ltd. and identify potential opportunities in those areas.

Save time and money with a subscription

Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?

To find out more, click here or call +44 1204 543 545.

  • ?
    Electronic PDF copy delivered via email.

    Report can be used by individual purchaser only.

  • ?
    Electronic PDF copy delivered via email.

    Report can be shared by unlimited users within one corporate location,
    e.g. a regional office.

  • ?
    Electronic PDF copy delivered via email.

    Report can be shared globally by unlimited users within the purchasing corporation
    e.g. all employees of a single company.

Add to cart
Not ready to buy yet?

Talk to us

Call us on +44 1204 543 529

Research Support

Get one-to-one support from our expert analysts only when you buy direct

Price Guarantee

You will not find our reports cheaper anywhere else

Customer Focused

Our client support team are on-hand to assist with your research needs

Unrivalled Expertise

700+ analysts delivering actionable insight